FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

CDER Right-to-Try Summaries Can Go Thru Portal

CDER updates its CDER NextGen Portal to allow Right to Try annual summary submissions for CDER-regulated products.

latest-news-card-1
Human Drugs

Guide on Tech Specs for NASH Drug Data Sets

FDA posts a final guidance entitled Technical Specifications for Submitting Clinical Trial Data Sets for Treatment of Noncirrhotic Nonalcoholic Steato...

latest-news-card-1
Human Drugs

FDA Promotes Centralized Statistical Trial Monitoring

FDA encourages drug sponsors to use centralized statistical monitoring to help keep an eye on clinical trial integrity issues.

latest-news-card-1
Human Drugs

McKinsey & Co. Pays $650 Million in Opioid Case

McKinsey & Co. agrees to pay $650 million to settle both criminal and civil investigations into its advisory work with Purdue Pharma and the marketing...

latest-news-card-1
Human Drugs

FDA Sees New Ocaliva Liver Injuries

FDA says it has identified serious liver injuries in patients without cirrhosis of the liver being treated for primary biliary cholangitis with Interc...

latest-news-card-1
Human Drugs

Keros Halts Some Dosing in Cibotercept Trial

Keros Therapeutics stops some dosing in a Phase 2 clinical trial of cibotercept (KER-012) in combination with background therapy in patients with pulm...

latest-news-card-1
Human Drugs

FDA Hasnt Inspected Factory with Recalls: ProPublica

A detailed ProPublica investigative report says FDA failed to inspect a Glenmark Pharmaceuticals facility in India that had multiple drug recalls in a...

latest-news-card-1
Human Drugs

Trump Unclear on Abortion Pills in Interview

In a Time interview, president-elect Donald Trump said it has always been his commitment to preserve access to abortion pills, but also said the issue...

latest-news-card-1
Human Drugs

Generics Seek Legislation to End Drug Sameness Delays

The Association for Accessible Medicines urges Congress to pass pending legislation to allow FDA to disclose sameness information about a brand drug t...

Human Drugs

FDA Launches RWE Evidence Innovation Center

FDA launches the CDER Center for Real-World Evidence Innovation with four areas of initial focus.